Better Choice Q1 2023 net sales $9.2M, gross margin up to 35.1% from 27.7%

SRx Health Solutions, Inc.

2023-Q1 EPS reported -$0.11 revenue$9,237,000

Net sales $9.2M vs $17.0M in Q1 2022, down 46% YoY; gross sales $12.4M.
Gross margin 35.1% vs 27.7% YoY; loss from operations improved to $3.3M from $4.0M.
Adjusted EBITDA loss $1.9M vs $2.0M; net loss $3.5M ($0.11 per share) vs $4.0M ($0.14).
E-commerce net sales $3.9M, International $2.3M, Brick & Mortar $1.7M, DTC $1.3M.
New CEO Kent Cunningham appointed; company expects improved balance sheet and operating efficiencies.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

SRx Health Solutions, Inc. reported financial results for first quarter ended March 31, 2023.

Period: first quarter ended March 31, 2023
Result: reported results

Exact text from the filing

On May 12, 2023, Better Choice Company Inc., a Delaware corporation (the “ Company ”), announced its financial results for the first quarter ended March 31, 2023. A copy of the press release is attached hereto as Exhibit 99.1.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-017843

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.